Abiopharma

🔍 Gallagher John E (Executive)

Company: Certara, Inc. (CERT)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 23,346 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 69,874.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 7,775 shares of Common Stock at $5.7 per share (Direct)
  Date: 2026-04-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 62,099.00 | transaction_form_type: 4 | Footnotes: F2, F1
• Acquired 12,633 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 74,732.00 | transaction_form_type: 4 | Footnotes: F3
• Sold 4,327 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 70,405.00 | transaction_form_type: 4 | Footnotes: F2, F3
• Acquired 15,190 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 85,595.00 | transaction_form_type: 4 | Footnotes: F4
• Sold 5,203 shares of Common Stock at $5.7 per share (Direct)
  Date: 2026-04-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 80,392.00 | transaction_form_type: 4 | Footnotes: F2, F4
• Acquired 22,782 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 103,174.00 | transaction_form_type: 4 | Footnotes: F5
• Sold 7,803 shares of Common Stock at $5.7 per share (Direct)
  Date: 2026-04-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 95,371.00 | transaction_form_type: 4 | Footnotes: F2, F5
• Sold 12,633 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-01 | Code: M | Expires: 2026-04-01 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3, F3
• Sold 15,190 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-01 | Code: M | Expires: 2027-04-01 | equity_swap_involved: 0 | shares_owned_after: 15,191.00 | transaction_form_type: 4 | Footnotes: F4, F4
• Sold 22,782 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-01 | Code: M | Expires: 2028-04-01 | equity_swap_involved: 0 | shares_owned_after: 45,566.00 | transaction_form_type: 4 | Footnotes: F5, F5

Footnotes:

• F1: Each performance stock unit ("PSU") was granted on April 1, 2023, under the Certara, Inc. ("Certara") 2020 Incentive Plan (the "2020 Incentive Plan") and represents a right to receive one share of common stock. The PSUs were subject to the achievement of certain performance objectives over a three-year period from January 1, 2023, to December 31, 2025. The PSUs were vested and settled on April 1, 2026.
• F2: Represents shares of Certara withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") and PSUs described in footnotes 1, 3, 4, and 5, exempt under Rule 16b-3.
• F3: Each RSU was granted on April 1, 2023, under the 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent. One-third of the RSUs vested and were settled on April 1, 2024. One-third of the RSUs vested and were settled on April 1, 2025. The remaining one-third of the RSUs vested and settled on April 1, 2026.
• F4: Each RSU was granted on April 1, 2024, under the 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent. One-third of the RSUs vested and were settled on April 1, 2025. One-third of the RSUs vested and were settled on April 1, 2026. The remaining one-third of the RSUs will vest and settle on April 1, 2027.
• F5: Each RSU was granted on May 20, 2025, under the 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent. One-third of the RSUs vested and were settled on April 1, 2026. The remaining two-thirds of the RSUs will vest and settle in equal parts on April 1, 2027 and April 1, 2028.